This case study explores the collaboration between Katalyze AI and a top-10 global biopharmaceutical company to develop a state-of the-art AI-enabled analytics platform for their vaccine production. Using an AI-enabled platform, the project digitized raw material data, applied predictive analytics, and introduced real-time monitoring to improve process efficiency. The initiative has already increased production yield by 3-5% and is on track to save 10 million annually per site by reducing deviations and root-cause analysis time. This project demonstrated AI's transformative potential in biomanufacturing, providing a scalable solution for enhanced product quality and supply chain reliability.
Reza Mastery Farahani (Mon,) studied this question.